Trials / Conditions / Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

4 registered clinical trials studyying Moderate to Severe Allergic Asthma.

Status	Trial	Sponsor	Phase
Unknown	A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE) NCT06348407	The First Affiliated Hospital with Nanjing Medical University	—
Terminated	A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Parti NCT04195958	Genentech, Inc.	Phase 4
Terminated	CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma NCT01673672	Cytos Biotechnology AG	Phase 2
Completed	Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moder NCT01362621	Novartis Pharmaceuticals	—